glp-1 for mash Incretin-based therapies in MASLD/MASH: from receptor agonists to dual and triple agonists Semaglutide approved for MASH treatment:

Its not a sign that youve failed or that your body is broken

A helix propensity scale based on experimental studies of peptides and proteins

Serious hypersensitivity reactions including anaphylaxis and angioedema have been reported with Ozempic Warnings and Precautions Risk of Thyroid C-Cell Tumors: Patients should be further evaluated if serum calcitonin is measured and found to be elevated or thyroid nodules are noted on physical examination or neck imaging Acute Pancreatitis: Acute pancreatitis, including fatal and nonfatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with GLP-1 receptor agonists, including semaglutide

Current evidence does not support a direct causal relationship between Ozempic and anger issues, but individual experiences may vary, and further research into the psychological effects of GLP-1 agonists would be valuable